Loading...
XSHE
002742
Market cap295mUSD
Dec 05, Last price  
4.83CNY
1D
2.11%
1Q
-1.02%
Jan 2017
-56.60%
IPO
-29.61%
Name

Chongqing Sansheng Industrial Co Ltd

Chart & Performance

D1W1MN
XSHE:002742 chart
P/E
P/S
1.75
EPS
Div Yield, %
Shrs. gr., 5y
0.07%
Rev. gr., 5y
-17.77%
Revenues
1.20b
-41.10%
847,780,9471,061,736,9861,173,970,2241,270,806,3931,410,854,3681,512,803,8551,902,471,9162,865,241,7533,180,117,0492,549,509,8572,489,145,2222,077,023,5642,030,233,4661,195,718,179
Net income
-650m
L+43.82%
87,232,638102,480,873102,549,383101,063,981121,762,022117,914,663180,330,725110,837,999124,835,09873,436,77200-452,046,680-650,130,617
CFO
0k
P
33,301,00523,514,8030056,077,731125,118,623179,347,7020154,662,019140,899,447139,837,80549,115,363-51,594,6010
Dividend
Jul 01, 20200.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chongqing Sansheng Industrial Co.,Ltd. engages in the research and development, production, and sale of building materials and chemicals in China. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy and hydropower, etc.; and sulfuric acid for the production of chemical fertilizers, chemical, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises. It also provides pharmaceutical products comprising intermediates, such as procaine hydrochloride, cefoxitin intermediate, chloramphenicol intermediate, aztreonam intermediate, orlistat intermediate, etc., which are used in antibiotic drugs, anti-hepatitis C drugs, diabetes medicines, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benoate, procaine hydrochloride, diphenhydramine hydrochloride, etc.; and preparation products, such as compound paracetamol diphenhydramine, cloperidine hydrochloride, clarithromycin sustained-release, diclofenac sodium enteric-coated, acetaminophen, famotidine tablets, etc., which are used in antipyretic and analgesic, antiviral, antibacterial, cough, allergy, local anesthesia, etc., as well as famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, and norfloxacin drugs for clinical needs. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. The company was founded in 2002 and is based in Chongqing, China.
IPO date
Feb 17, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT